PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
ASX:PYC
Price:
0.105 AUD
5%
Market Closed
Updated:
May 31, 2024
PYC Therapeutics Ltd
Total Current Liabilities
|
PYC Therapeutics Ltd
Total Current Liabilities Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Total Current Liabilities
AU$8.6m
|
CAGR 3-Years
95%
|
CAGR 5-Years
39%
|
CAGR 10-Years
26%
|
|
|
Immutep Ltd
ASX:IMM
|
Total Current Liabilities
AU$6.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Total Current Liabilities
$31.4m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Total Current Liabilities
$4.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
20%
|
CAGR 10-Years
20%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Total Current Liabilities
AU$29.4m
|
CAGR 3-Years
51%
|
CAGR 5-Years
63%
|
CAGR 10-Years
32%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Total Current Liabilities
AU$157.4m
|
CAGR 3-Years
99%
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
See Also
What is PYC Therapeutics Ltd's Total Current Liabilities?
Total Current Liabilities
8.6m
AUD
8.6m
AUD
Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's Total Current Liabilities amounts to 8.6m AUD.
What is PYC Therapeutics Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
26%
26%
Over the last year, the Total Current Liabilities growth was 7%. The average annual Total Current Liabilities growth rates for PYC Therapeutics Ltd have been 95% over the past three years , 39% over the past five years , and 26% over the past ten years .
You don't have any saved screeners yet
